NEWLY DIAGNOSED GLIOBLASTOMA
Clinical trials for NEWLY DIAGNOSED GLIOBLASTOMA explained in plain language.
Never miss a new study
Get alerted when new NEWLY DIAGNOSED GLIOBLASTOMA trials appear
Sign up with your email to follow new studies for NEWLY DIAGNOSED GLIOBLASTOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New brain cancer vaccine trial seeks to train immune system
Disease control Recruiting nowThis study is testing a new vaccine designed to help the body's immune system fight glioblastoma, a serious brain cancer. It will be given to 35 patients who have already received standard surgery and radiation/chemotherapy. The main goals are to find a safe dose and see if the v…
Matched conditions: NEWLY DIAGNOSED GLIOBLASTOMA
Phase: PHASE1, PHASE2 • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control
Last updated Mar 30, 2026 14:34 UTC
-
Scientists use ultrasound to unlock brain, supercharge cancer fight
Disease control Recruiting nowThis study is testing a new approach for treating glioblastoma, a very aggressive brain cancer. Researchers are implanting a small ultrasound device in the brain to temporarily open the protective blood-brain barrier. The goal is to allow powerful immune-boosting drugs to better …
Matched conditions: NEWLY DIAGNOSED GLIOBLASTOMA
Phase: PHASE2 • Sponsor: Northwestern University • Aim: Disease control
Last updated Mar 23, 2026 15:18 UTC
-
Brain cancer breakthrough? new drug duo aims to supercharge immune system
Disease control Recruiting nowThis study is testing whether adding a second immunotherapy drug (relatlimab) to an existing one (nivolumab) can better help the body's immune system fight a fast-growing brain tumor called glioblastoma. About 92 adults with newly diagnosed glioblastoma will receive the drug comb…
Matched conditions: NEWLY DIAGNOSED GLIOBLASTOMA
Phase: PHASE2 • Sponsor: Duke University • Aim: Disease control
Last updated Mar 16, 2026 15:27 UTC